| General Information of Drug Metabolite (DM) (ID: DM007016) |
| DM Name |
Norcisapride (M16)
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 (CYP)
|
DMEN060
|
| Oxidation - Oxidationn |
Norcisapride
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Norcisapride |
DR1780
|
Discontinued |
Gastro-oesophageal reflux disease |
|
|
| References |
| 1 |
Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms. Drug Metab Dispos. 2001 Dec;29(12):1548-54.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
